do glp 1 cause pancreatic cancer Frontiers Do GLP-1–Based Therapies Increase Cancer

There isnt enough evidence to determine whether retatrutide is safe

In pharma, a similar algorithm could propose novel bioreactor shapes or mixing strategies

Ro published a real-world outcomes study in Obesity journal on December 10, 2025

In the HARMONY-7 trial (once-weekly albiglutide versus once-daily liraglutide in patients with T2D inadequately controlled on oral drugs)89), participants were randomized to receive either a 30-mg dose of albiglutide once weekly, titrated to a 50-mg dose once weekly after 6 weeks, or a 0.6 mg daily dose of liraglutide, titrated to 1.8 mg after 2 weeks

Their study primarily concentrated on overall usage trends of DPP-4 inhibitors and provided the usage proportions of specific drugs, such as sitagliptin

Finally, ongoing or recently completed, yet unpublished, RCTs are expected to provide additional information on the comparative effects of tirzepatide vs other glucose-lowering agents, including dulaglutide (ClinicalTrials.gov registration no